Novadip Biosciences to unveil its 3M3 platform at BIO Digital 2020

Novadip Biosciences, a clinical-stage biopharmaceutical company leveraging its tissue regeneration technology platform to generate multiple product candidates, will unveil details of its 3M3 miRNA delivery platform in a recorded presentation